Magnetic Resonance Imaging as an Early Indicator of Clinical Outcome in Patients With Metastatic Colorectal Carcinoma Treated With Cetuximab or Panitumumab
Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2012.07.001
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2013
Authors
Publisher
Elsevier BV